Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New findings in the area of cancer vaccines described
November 18th, 2005
Investigators in the United States and Australia have published new cancer vaccines data. Study 1: Researchers present the structural basis for antagonism by suramin of heparin binding to vaccinia complement protein in a recent issue of Biochemistry. According to recent research from the United States, "Suramin is a competitive inhibitor of heparin binding to many proteins, including viral envelope proteins, protein tyrosine phosphatases, and fibroblast growth factors (FGFs). It has been clinically evaluated as a potential therapeutic in treatment of cancers caused by unregulated angiogenesis, triggered by FGFs. Although it has shown clinical...
Source: Drug Week (2005-11-18)
|
